Home EIPG Newsletter

EIPG Newsletter

From Malta: Preparations for the impact of Brexit on the pharmaceutical supply chain in...

Malta is heavily dependent upon the United Kingdom and Ireland for the supply of medicinal products. Preparations to limit the impact of the Brexit on the import of pharmaceutical products still lag behind, with the possible risk of shortage of medicines on the island after 30 March 2019

Italy has overtaken Germany as for pharmaceutical production

The total value of the Italian pharmaceutical production is ranking n. 1 in EU-28, marking the overtake of Germany and behind only to Switzerland. Data from the Italian pharmaceutical industry association Farmindustria show the very good health of the sector, which continued its growth in the past decade despite of the economical crisis affecting the country

Pharma companies are not yet ready for the Brexit

According to the survery run by EMA, many pharma companies based in the UK did not yet planned the activation of the necessary regulatory procedures to prepare for the Brexit. UK's new position of third country might require transfer of MAHs, batch release, quality control, site of import, QPPV and PSMF

Pre-clinical to clinical boundary, the key to success

The correct identification of the pre-clinical to clinical boundary may represent the key to success for early-stage development of pharmaceuticals. The issue has been discussed in a joint workshop held by UK's Association of British Pharmaceutical Industry and the Academy of Medical Sciences

Monthly update from EIPG: Consultation calls and Coming into effect documents

Several consultation calls relevant for industrial pharmacists are closing by the end of September 2018. A dedicated page on the EIPG's website also summarises guidelines coming into effect on 1st September 2018

The Membership of EIPG

EIPG represents at the European level the national, professional organisations of pharmacists employed in the pharmaceutical or allied industries. Its 16 Members Associations are involved in the education and promotion of the figure of industrial pharmacists and in dealing with technical issues typical of their role within the pharmaceutical industry

3D printing, a disruptive technology still lacking regulatory guidance in the EU

Additive manufacturing offers a great potential for the manufacturing of pharmaceutical products, but it is a very complex process and still lacking regulatory guidance in the EU. In the US, the FDA published in 2017 a guideline for the additive manufacturing of medical devices

The new Horizon Europe is coming

Horizon Europe, the new FP9 European framework programme for research and innovation, is due to start in 2021 and shall focus on Open Science and sharing of excellence. A mission-oriented approach based on real needs coming from EU's citizens is at the centre of the proposal of the European Commission

From Italy: The main themes discussed at the annual AFI Symposium

All main themes in the field of pharmaceuticals have been addressed during the 58°AFI Symposium, the annual meeting of the Italian pharmaceutical industry this year attended by more than 1,400 participants

UK invests in industrial biotechnologies, innovation and talents

Many initiatives are undergoing in UK in order to improve the global competitiveness of the country in the field of industrial biotechnologies, R&D activities for the manufacturing of small molecules, attraction of international talents and capital investments in innovation and research